Exact Sciences
EXAS
#1382
Rank
C$17.75 B
Marketcap
$96.07
Share price
2.34%
Change (1 day)
-5.23%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : C$4.72 B

According to Exact Sciences's latest financial reports the company's total liabilities are C$4.72 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Exact Sciences - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31C$4.41 B2.11%
2022-12-31C$4.32 B3.53%
2021-12-31C$4.17 B21.67%
2020-12-31C$3.42 B117.27%
2019-12-31C$1.57 B37.26%
2018-12-31C$1.15 B1070.66%
2017-12-31C$98.24 M75.13%
2016-12-31C$56.09 M8.67%
2015-12-31C$51.62 M86.7%
2014-12-31C$27.65 M129.78%
2013-12-31C$12.03 M-10.72%
2012-12-31C$13.47 M-1.54%
2011-12-31C$13.68 M-18.41%
2010-12-31C$16.77 M-19.06%
2009-12-31C$20.72 M103.63%
2008-12-31C$10.17 M24.99%
2007-12-31C$8.14 M-21.49%
2006-12-31C$10.37 M-32.62%
2005-12-31C$15.39 M-22.17%
2004-12-31C$19.78 M-32.79%
2003-12-31C$29.43 M58.77%
2002-12-31C$18.53 M181.55%
2001-12-31C$6.58 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
C$0.46 B-90.10%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.13 B-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.58 M-99.37%๐Ÿ‡บ๐Ÿ‡ธ USA
C$82.52 B 1,647.92%๐Ÿ‡ซ๐Ÿ‡ท France